Innate Pharma (IPHA) Announces FDA Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell Lymphomas Jun 24, 2020 06:26AM
U.S. Food and Drug Administration Lifts Partial Clinical Hold on Lacutamab TELLOMAK Trial in Advanced T-Cell Lymphomas Jun 24, 2020 01:00AM
French Regulatory Agency Agrees lacutamab TELLOMAK Trial Can Resume Recruitment in Sezary Syndrome and mycosis fungoides Jan 13, 2020 05:00PM
Innate Pharma Provides Update from Regulatory Agencies on Lacutamab TELLOMAK Trial Jan 9, 2020 01:00AM
Innate Pharma Provides Update on Lacutamab TELLOMAK Trial Dec 13, 2019 01:00AM